Advertisement

Epidemiology

Chapter

Abstract

Dyspepsia includes an array of gastrointestinal symptoms present in individuals all over the world, in industrialized countries in particular. A great proportion of individuals visiting primary healthcare offices or gastrointestinal clinics suffer from dyspepsia. However, the true epidemiology of dyspepsia is difficult to assess because of variability in the definition of dyspepsia that would be applicable in all populations, along with variable patient description of dyspeptic symptoms and interpretation of these symptoms by physicians.

Keywords

Dyspepsia Epidemiology Overlap syndrome Uninvestigated dyspepsia 

References

  1. 1.
    Locke III GR. Prevalence, incidence and natural history of dyspepsia and functional dyspepsia. Baillières Clin Gastroenterol. 1998;12:435–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Talley NJ, Zinsmeister AR, Schleck CD, Melton III LJ. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102:1259–68.PubMedGoogle Scholar
  3. 3.
    Talley NJ, Weaver AL, Zinsmeister AR, Melton III LJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol. 1992;136:165–77.PubMedGoogle Scholar
  4. 4.
    Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Haag S, Senf W, Häuser W, et al. Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther. 2008;27:561–71.PubMedCrossRefGoogle Scholar
  6. 6.
    Haycox A, Einarson T, Eggleston A. The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999;231:38–47.PubMedGoogle Scholar
  7. 7.
    Moayyedi P, Forman D, Braunholtz D, et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol. 2000;95:1448–55.PubMedCrossRefGoogle Scholar
  8. 8.
    Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ. 1991;302:749–52.PubMedCrossRefGoogle Scholar
  9. 9.
    Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tygat GN. Functional gastroduodenal disorders. Gut. 1999;45 Suppl 2: II37–42.PubMedCrossRefGoogle Scholar
  10. 10.
    Kay L, Jorgensen T. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol. 1994;29:2–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J. 2000;113:178–81.PubMedGoogle Scholar
  12. 12.
    Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol. 1998;93:1816–22.PubMedCrossRefGoogle Scholar
  13. 13.
    Locke III GR, Zinsmeister AR, Melton III LJ, Talley NJ. Overlap of gastrointestinal symptom complexes in the community. Am J Gastroenterol. 2003;98:S273.CrossRefGoogle Scholar
  14. 14.
    Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004;99:2210–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol. 2002;37:917–23.PubMedCrossRefGoogle Scholar
  16. 16.
    Jones RH, Lydeard SE, Hobbs FD, et al. Dyspepsia in England and Scotland. Gut. 1990;31:401–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut. 1996;38:822–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Hirakawa K, Adachi K, Amano K, et al. Prevalence of non-ulcer dyspepsia in the Japanese population. J Gastroenterol Hepatol. 1999;14:1083–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Jurčić D, Bilić A. Rational approach to the patient with dyspepsia. Medicus. 2006;15:15–23.Google Scholar
  20. 20.
    Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–79.PubMedCrossRefGoogle Scholar
  21. 21.
    Quigley EM, Koehane J. Dyspepsia. Curr Opin Gastroenterol. 2008;24:692–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Keohane J, Quigley EM. Functional dyspepsia and nonerosive reflux disease: clinical interactions and their implications. MedGenMed. 2007;9:31.PubMedGoogle Scholar
  23. 23.
    El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643–54.PubMedCrossRefGoogle Scholar
  24. 24.
    Halder SL, Locke III GR, Schleck CD, Zinsmeister AR, Melton III LJ, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007;133:799–807.PubMedCrossRefGoogle Scholar
  25. 25.
    Tutega AK, Talley NJ, Joos SK, Hickam DH. Overlap of functional dyspepsia and irritable bowel syndrome in a community sample. Am J Gastroenterol. 2003;98:S272.CrossRefGoogle Scholar
  26. 26.
    Minocha A, Chad W, Do W, Johnson WD. Racial differences in epidemiology of irritable syndrome alone, un-ivestigated dyspepsia alone, and “overlap syndrome” among african americans compared to Caucasians: a population-based study. Dig Dis Sci. 2006;51:218–26.PubMedCrossRefGoogle Scholar
  27. 27.
    Geeraerts B, Vandenberghe J, Van Oudenhove L, et al. Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology. 2005;129:1437–44.PubMedCrossRefGoogle Scholar
  28. 28.
    Wigington WC, Johnson W, Cosman C, et al. Comprehensive description of irritable bowel syndrome by subtypes in African-Americans versus Caucasians. Am J Gastroenterol. 2003;98:S267.CrossRefGoogle Scholar
  29. 29.
    Halder SL, Locke III GR, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogas­troenterol Motil. 2006;18:1001–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: non-steroidal anti-infammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand J Gastroenterol. 2006;41:149–54.PubMedCrossRefGoogle Scholar
  31. 31.
    Cremonini F, Locke III GR, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006;18:987–94.PubMedCrossRefGoogle Scholar
  32. 32.
    Lu CL, Lang HC, Chang FY, et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol. 2005;40:402–11.PubMedCrossRefGoogle Scholar
  33. 33.
    Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002;97:2290–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study. Am J Gastroenterol. 1999;94: 2845–54.PubMedCrossRefGoogle Scholar
  35. 35.
    Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton III LJ. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995;40:1345–50.PubMedCrossRefGoogle Scholar
  36. 36.
    Marušić M, Presečki V, Katičić M, Bilić A, Jurčić D, Schwarz D. Seroprevalence of Helicobacter pylori infection in dyspeptic patients. Coll Antropol. 2008;32:1149–53.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2011

Authors and Affiliations

  1. 1.Department of Gastroenterology and Hepatology, University Department of MedicineZagreb University HospitalZagrebCroatia

Personalised recommendations